Britain gave the green signal for the Chennai-based Shasun Chemicals and Drugs Ltd on Wednesday for supplying medicines that would soon hit the European markets soon.
With the approval from the British Medicines and Healthcare products Regulatory Agency (MHRA), Shasun's products from its formulation facility in Pondicherry can now be sold in Britain and other European countries.
Shasun's plant at Pondicherry, set up in 2005, has a capacity to produce 3.6 billion tablets per year.
"With this first approval for the formulation plant having been received in record time, the company is closer to commercialising its plan in integrating its support operations in the complete value chain of pharma business," Vimal Kumar, Shasun's joint managing director told reporters Wednesday.
"Going forward, we expects this approval to enhance our capabilities to support the requirements of companies worldwide, providing back end manufacturing support across the complete pharmaceutical value chain," he said.